Managing Partner

Antoine Papiernik is a Managing Partner and he invests in life sciences. He joined Sofinnova Partners in 1997, and was previously with CDC-Innovation, the venture arm of  the Caisse des Dépôts group. Since joining Sofinnova Partners, Antoine has been an initial investor and active board member in public companies like Actelion, Addex, Orexo, NovusPharma and Movetis, which went public respectively on the Zürich stock exchange, the Stockholm stock exchange, the Milan Nuovo Mercato, and the Belgium Stock Exchange, in Cotherix (initially NASDAQ listed, then sold to Actelion), CoreValve (sold to Medtronic) and Fovea (sold to Sanofi Aventis). He has also invested in and is a board member of private companies CoAxia, EOS, Lectus, SpineVision and Stentys. Antoine has an MBA from the Wharton School of Business, University of Pennsylvania.